Wednesday, 3 July 2013

FDA grants priority review to Roche's leukemia drug

ZURICH (Reuters) - Swiss drugmaker Roche Holding AG said on Wednesday U.S. health regulators have granted priority review to its experimental leukemia treatment GA101.

via Reuters: Health News Read More Here..

No comments:

Post a Comment